Skip to main content
  • Clariant Logo
  • 分享
  • 联系信息
  • CN - US
  • Translate
  • Contrast
  • 搜索
  • 产品与行业
  • 可持续发展
  • 公司
  • 媒体
  • 投资者
  • Careers
  • 活动
  • 咨询产品
关闭
搜索
关闭
SDS & Document Finder
result(s)
所有结果
关闭
科莱恩领英 电子邮件 更多选择
关闭
关闭
The translation will be performed automatically using AI. Please double-check important facts and statements.
关闭
Clariant International
  • 产品与行业
  • 可持续发展
  • 公司
  • 媒体
  • 投资者
  • Careers
  • 活动
  • 咨询产品
科莱恩中国
官方微信公众号
科莱恩中国
首页 / 科莱恩化工 Clariant Chemicals / 科莱恩新闻 / Achieve higher efficacy of Retinol with Clariant…
News
摘要
2022年11月23日

Achieve higher efficacy of Retinol with Clariant's VitiSpheres® R8

个人护理 创新 业务发布 全球
Minimum concentration for optimal effect: Clariant's encapsulated Retinol VitiSpheres R8.
  • Advanced drop-in encapsulated Retinol allows safe use of high concentrations
  • New data highlights ability to protect Retinol’s stability, promote better bioavailability, and enhance its skin penetration – for higher efficacy
  • Proven non-irritating formulation ingredient thanks to controlled release of Retinol

MUTTENZ, November 23, 2022 - Cosmetics brands can now help more consumers to get the most out of introducing the benefits of Retinol into their skincare routines. Available worldwide, Clariant’s encapsulated Retinol VitiSpheres R8 makes it possible to protect the Retinol’s proven anti-aging potency and use higher concentrations safely in creams and serums.

“While consumers across all generations are increasingly seeking out Retinol for its benefit in reducing the appearance of wrinkles, it does have two drawbacks which dramatically lower its potential use. It can cause irritations when not properly dosed, and it is not stable in cosmetic formulations, meaning its properties can degrade prior to application. VitiSpheres R8 overcomes these challenges: it stabilizes the Retinol in formulations over time and enables a controlled, prolonged release into the epidermis skin layer where it will be most effective. Brands and formulators benefit from stable, well-protected Retinol which expands possibilities for higher efficacy products suited to a broad range of skin types,” comments Thomas Lukowicz, Clariant Global Application Development Manager.

Clariant’s unique multilayer encapsulated Retinol is an easy-to-formulate, drop-in solution for formulators to deliver high molecule charges without compromising skin.

In VitiSpheres R8, Retinol molecules are uniquely held within the solid-lipid core of a leak-proof multilayered capsule. The patented system protects the Retinol from oxidation, ensuring very good stability in formulations compared to benchmark systems. This maintains bioavailability of the Retinol, and reduces the potential loss of beneficial properties both during formulating as well as over a long shelf life.

Importantly, Retinol is only released on skin contact at skin temperature. The encapsulated ingredient melts on application and opens the pathway for Retinol to be released smoothly and gradually into the skin where it will be most effectively taken up, avoiding the potential of a sudden irritation-inducing Retinol overload even at high concentrations.

Its superior Retinol penetration compared to other systems and skin tolerance is confirmed by data – supporting both higher efficacy and the possibility to use higher concentrations in formulations.

For more information on VitiSpheres R8 technology and to request a sample visit VitiSpheres R8 (clariant.com). 

VitiSpheres® IS A TRADEMARK OF CLARIANT REGISTERED IN MANY COUNTRIES. 


Documents

  • Media Release Vitispheres R8 20221123 EN (0.22 MB)

Related Images & Video

  • Minimum concentration for optimal effect: Clariant's encapsulated Retinol VitiSpheres R8. (4.77 MB)
Read all news
Clariant International
          Clariant International
          我们了解客户的需求,提供有竞争力和创新的解决方案,从而为客户创造更多价值。我们的员工需要 – 恪守公司的价值观。我们的股东需要 – 实现超出平均值的投资回报。我们的环境需要 – 实现可持续发展。
          科莱恩中国
          官方微信公众号
          科莱恩中国
          • 使用条款
          • 版权标记
          • 科莱恩领英
          • 科莱恩1688官方旗舰店
          • 联系我们
          • 沪 ICP 备 2021003227 号-1
          版权所有©科莱恩2024年。保留所有权利。

          页面摘要

          close
          摘要生成中
          页面摘要由人工智能生成